Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
KB Home
KBH
Meritage Homes
MTH
US Stock MarketDetailed Quotes
XTLB XTL Biopharmaceuticals
- 1.820
- -0.250-12.08%
Trading Dec 30 15:33 ET
9.92MMarket Cap-58.71P/E (TTM)
1.890High1.800Low21.49KVolume1.890Open2.070Pre Close39.53KTurnover0.52%Turnover RatioLossP/E (Static)5.45MShares4.99052wk High3.67P/B7.52MFloat Cap0.76852wk Low--Dividend TTM4.13MShs Float600.000Historical High--Div YieldTTM4.35%Amplitude0.625Historical Low1.839Avg Price1Lot Size
XTL Biopharmaceuticals News
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 20-F: FY2023 Annual Report
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 20-F: FY2022 Annual Report
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.